跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pantolev - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Pantolev
Approved
STANDARD
Pantolev
gufic stridden bipharma pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c3b011160bde765e
Company
gufic stridden bipharma pvt. Ltd.
Type
Standard
Approval Details
Approval Id
c3b011160bde765e
Drug Approval Philippines Name
Pantolev
Product Name
Pantolev
Registration Number
DRP-5303-02
Brand Name
Pantolev
Generic Name
Pantoprazole (as sodium sesquihydrate)
Dosage Form
Lyophilized Powder For Injection (IV)
Dosage Strength
40 mg
Manufacturer
gufic stridden bipharma pvt. Ltd.
Importer
Suhitas pharmaceuticals, inc.
Distributor
HLM Leverage
Issuance Date
27 March 2024
Expiry Date
19 May 2029
Pharmacologic Category
Proton Pump Inhibitors
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c3b011160bde765e
Type
Standard
Back to Philippines FDA Approvals